We sought to determine the expression of HER2 and ATM at the protein and mRNA levels in bladder cancer cohorts to understand their relationship and investigate their impact on patient survival and cancer aggressiveness. The gene discussed is ERBB2; the disease is urinary bladder carcinoma.